Artigo Revisado por pares

Impact of Nocturia on Mortality: The Nagahama Study

2020; Lippincott Williams & Wilkins; Volume: 204; Issue: 5 Linguagem: Inglês

10.1097/ju.0000000000001138

ISSN

1527-3792

Autores

Satoshi Funada, Yasuharu Tabara, Kazuya Setoh, Hiromitsu Negoro, Shusuke Akamatsu, Takayuki Yoshino, Koji Yoshimura, Norio Watanabe, Toshi A. Furukawa, Fumihiko Matsuda, Osamu Ogawa,

Tópico(s)

Bladder and Urothelial Cancer Treatments

Resumo

No AccessJournal of UrologyAdult Urology1 Nov 2020Impact of Nocturia on Mortality: The Nagahama StudyThis article is commented on by the following:Editorial Comment Satoshi Funada, Yasuharu Tabara, Kazuya Setoh, Hiromitsu Negoro, Shusuke Akamatsu, Takayuki Yoshino, Koji Yoshimura, Norio Watanabe, Toshi A. Furukawa, Fumihiko Matsuda, and Osamu Ogawa Satoshi FunadaSatoshi Funada Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan More articles by this author , Yasuharu TabaraYasuharu Tabara Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author , Kazuya SetohKazuya Setoh Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author , Hiromitsu NegoroHiromitsu Negoro Department of Urology, University of Tsukuba Hospital, Ibaraki, Japan More articles by this author , Shusuke AkamatsuShusuke Akamatsu Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author , Takayuki YoshinoTakayuki Yoshino Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author , Koji YoshimuraKoji Yoshimura Department of Urology, Shizuoka General Hospital, Shizuoka, Japan More articles by this author , Norio WatanabeNorio Watanabe Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan More articles by this author , Toshi A. FurukawaToshi A. Furukawa Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan Financial interest and/or other relationship with Meiji, Mitsubishi-Tanabe, MSD and Pfizer, as well as a patent (2018-177688) pending. More articles by this author , Fumihiko MatsudaFumihiko Matsuda Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author , and Osamu OgawaOsamu Ogawa †Correspondence: Department of Urology, Kyoto University Graduate School of Medicine, 54, Shogoinkawahara-cho, Sakyo-ku Kyoto606-8507, Japan telephone: +81 75 751 3325; FAX: +81 75 761 3441; E-mail Address: [email protected] Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author for the Nagahama Study Group View All Author Informationhttps://doi.org/10.1097/JU.0000000000001138AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Nocturia has been reported as a risk factor for mortality. However, evidence is limited and has a high risk of bias. We evaluated the association between nocturia and mortality using longitudinal data from the general Japanese population. Materials and Methods: Data were obtained from the Nagahama Cohort Project, a longitudinal, general population cohort study. Nocturia was measured using the International Prostate Symptom Score. Mortality data were obtained from the Basic Resident Register in Nagahama City. We used Cox proportional hazard models and time-varying covariates at baseline and 5-year followup to analyze the association between nocturia and mortality. Results: We analyzed 9,762 participants (median age 56.8 years, male 32.8%). The prevalence rates of nocturnal voiding at 0, 1, 2 and 3 or more times were 44.3%, 39.1%, 11.7% and 4.9%, respectively. A total of 263 participants died. Followup assessment was performed 3,224 (SD 537) days after baseline. According to multivariable Cox proportional hazard regressions, mortality increased dose dependently with the nocturnal voiding frequency as HR 1.46 for 1 time (95% CI 1.02–2.09), HR 1.85 for 2 times (95% CI 1.23–2.77) and HR 2.06 (95% CI 1.28–3.32) for 3 or more times in comparison with 0 times (p for trend=0.00084). In the time varying Cox proportional hazard regression the association was still significant (p for trend=0.0017). Conclusions: According to this longitudinal study with a low incidence of missing data and high representation of the general population, nocturia is associated with mortality. REFERENCES 1. : International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn 2019; 8: 499. Google Scholar 2. : The prevalence and causes of nocturia. J Urol 2013; 189: S86. Link, Google Scholar 3. : What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol 2014; 65: 1211. Google Scholar 4. : Nocturia: aetiology and treatment in adults. Nat Rev Urol 2016; 13: 573. Google Scholar 5. : The impact of nocturia on mortality: a systematic review and meta-analysis. J Urol 2020; 203: 486. Link, Google Scholar 6. : Association of nocturia and mortality: results from the third national health and nutrition examination survey. J Urol 2011; 185: 571. Link, Google Scholar 7. : Cross-sectional epidemiological analysis of the Nagahama study for correlates of overactive bladder: genetic and environmental considerations. J Urol 2018; 199: 774. Link, Google Scholar 8. : Sleep disturbance worsens lower urinary tract symptoms: the Nagahama study. J Urol 2019; 354: 202. Google Scholar 9. : Longitudinal analysis of bidirectional relationships between nocturia and depressive symptoms: the Nagahama study. J Urol 2020; 203: 984. Link, Google Scholar 10. : Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index. Nihon Hinyokika Gakkai Zasshi 2002; 93: 669. Google Scholar 11. : Package “survival” title survival analysis 2019. Available at: https://cran.r-project.org/web/packages/survival/index.html. Accessed April 18, 2020. Google Scholar 12. : Using time dependent covariates and time dependent coefficients in the Cox model. Red 2020; 2. Google Scholar 13. : Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435. Google Scholar 14. : Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166: 1768. Google Scholar 15. : The impact of nocturia on falls and fractures: a systematic review and meta-analysis. J Urol 2020; 203: 674. Link, Google Scholar 16. Vital Statistics Japan (Ministry of Health, Labour and Welfare). Available at https://www.mhlw.go.jp/toukei/list/81-1a.html. Accessed February 12, 2020. Google Scholar No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. The Nagahama study was supported by a university grant, the Center of Innovation Program, the Global University Project, and a Grant-in-Aid for Scientific Research (25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, 18K18450) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Practical Research Project for Rare/Intractable Diseases (ek0109070, ek0109070, ek0109196, ek0109348), the Comprehensive Research on Aging and Health Science Research Grants for Dementia R&D (dk0207006, dk0207027), the Program for an Integrated Database of Clinical and Genomic Information (kk0205008), the Practical Research Project for Lifestyle-related Diseases including Cardiovascular Diseases and Diabetes Mellitus (ek0210066, ek0210096, ek0210116), and the Research Program for Health Behavior Modification by Utilizing IoT (le0110005), from Japan Agency for Medical Research and Development (AMED); the Takeda Medical Research Foundation; the Mitsubishi Foundation; the Daiwa Securities Health Foundation; and the Sumitomo Foundation. © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology4 Sep 2020Editorial Comment Volume 204Issue 5November 2020Page: 996-1002Supplementary Materials Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.Keywordscohort studiesnocturiamortalitylongitudinal studiesAcknowledgmentsThe Nagahama City Office and the nonprofit organization Zeroji Club provided assistance conducting the Nagahama Study. The Nagahama Study Group executive committee is composed of the following individuals: Yasuharu Tabara, Takahisa Kawaguchi, Kazuya Setoh, Yoshimitsu Takahashi, Shinji Kosugi, Takeo Nakayama and Fumihiko Matsuda from the Center for Genomic Medicine, Kyoto University Graduate School of Medicine (YaT, TK, KS, FM); the Department of Health Informatics (YoT, TN) and the Department of Medical Ethics and Medical Genetics (SK), Kyoto University School of Public Health.MetricsAuthor Information Satoshi Funada Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan More articles by this author Yasuharu Tabara Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author Kazuya Setoh Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author Hiromitsu Negoro Department of Urology, University of Tsukuba Hospital, Ibaraki, Japan More articles by this author Shusuke Akamatsu Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author Takayuki Yoshino Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author Koji Yoshimura Department of Urology, Shizuoka General Hospital, Shizuoka, Japan More articles by this author Norio Watanabe Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan More articles by this author Toshi A. Furukawa Department of Health Promotion and Human Behavior, Kyoto University School of Public Health, Kyoto, Japan Financial interest and/or other relationship with Meiji, Mitsubishi-Tanabe, MSD and Pfizer, as well as a patent (2018-177688) pending. More articles by this author Fumihiko Matsuda Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan More articles by this author Osamu Ogawa Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan †Correspondence: Department of Urology, Kyoto University Graduate School of Medicine, 54, Shogoinkawahara-cho, Sakyo-ku Kyoto606-8507, Japan telephone: +81 75 751 3325; FAX: +81 75 761 3441; E-mail Address: [email protected] More articles by this author Expand All No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. The Nagahama study was supported by a university grant, the Center of Innovation Program, the Global University Project, and a Grant-in-Aid for Scientific Research (25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, 18K18450) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Practical Research Project for Rare/Intractable Diseases (ek0109070, ek0109070, ek0109196, ek0109348), the Comprehensive Research on Aging and Health Science Research Grants for Dementia R&D (dk0207006, dk0207027), the Program for an Integrated Database of Clinical and Genomic Information (kk0205008), the Practical Research Project for Lifestyle-related Diseases including Cardiovascular Diseases and Diabetes Mellitus (ek0210066, ek0210096, ek0210116), and the Research Program for Health Behavior Modification by Utilizing IoT (le0110005), from Japan Agency for Medical Research and Development (AMED); the Takeda Medical Research Foundation; the Mitsubishi Foundation; the Daiwa Securities Health Foundation; and the Sumitomo Foundation. Advertisement PDF downloadLoading ...

Referência(s)
Altmetric
PlumX